胃癌组织中MGMT、RASSF1A基因启动子区甲基化研究
The Expression and Promoter Hypermethylation Status of MGMT, RASSF1A in Gastric Cancer
DOI: 10.12677/WJCR.2014.42004, PDF, HTML, 下载: 2,783  浏览: 9,492  科研立项经费支持
作者: 鞠昕丽:大连医科大学,大连;黄俊谦, 宋明全, 姜相君:青岛市市立医院消化内二科,青岛
关键词: 胃癌甲基化特异性PCRMGMTRASSF1AGastric Cancer; Methylation-Specific PCR; MGMT Gene; RASSF1A Gene
摘要: 目的:探讨MGMT、RASSF1A启动子甲基化状况在胃癌发生、发展中的作用。方法:用甲基特异性聚合酶扩增链式反应(methylation specific PCR, MSP)检测60例胃癌组织及相应癌旁正常组织MGMT、RASSF1A基因启动子的甲基化状况,用实时荧光定量逆转录–多聚合酶链反应(real-time RT-PCR)和免疫组织化学SP法分别检测基因MGMT、RASSF1A的mRNA和蛋白的表达情况。结果:胃癌组织中MGMT、RASSF1A基因的甲基化阳性率较正常组织明显升高(P < 0.05)。胃癌组织中MGMT和RASSF1AmRNA阳性表达率明显低于正常组织(P < 0.05)。胃癌组织MGMT、RASSF1A蛋白表达明显低于正常组织。结论:胃癌组织中存在一定程度的MGMT、RASSF1A基因启动子高甲基化和蛋白表达缺失,是胃癌发生的重要途径之一。
Abstract: Objective: To investigate the functions of hypermethylation of MGMT and RASSF1A genes in human gastric cancer. Methods: Methylation status of the MGMT and RASSF1Agenes in 60 gastric carcinoma tissues and 60 paired surgical marginal normal gastric tissues were detected using methylation-specific PCR. Real-time RT-PCR was used to detect the expression of MGMT and RASSF1A, and immunohistochemistry was used to detect the expression of MGMT and RASSF1Aproteins in the above samples. Results: The positive rates of promoter methylation of the MGMT and RASSF1Agenes were significantly higher in gastric cancer than those in normal tissue (both P < 0.05). The positive rates of MGMT and RASSF1AmRNA expression in gastric cancer were significantly lower than those in normal tissues (both P < 0.05). The expression of MGMT and RASSF1A proteins were significantly higher in gastric cancer than those in normal tissue. Conclusion: Hypermethylation of CpG island and loss of the expression in MGMT and RASSF1A genes were existed in gastric cancer, and it possibly plays a key role in carcinogenesis of gastric cancer.
文章引用:鞠昕丽, 黄俊谦, 宋明全, 姜相君. 胃癌组织中MGMT、RASSF1A基因启动子区甲基化研究[J]. 世界肿瘤研究, 2014, 4(2): 18-24. http://dx.doi.org/10.12677/WJCR.2014.42004

参考文献

[1] Peedicayil, J. (2007) The role of epigenetics in mental disorders. Indian Journal of Medical Research, 126, 111.
[2] Balin, S.B. and Ohm, J.E. (2006) Epigenetic gene silencing in cancer—A mechanism for early oncogenic pathway addiction. Nature Reviews Cancer, 2, 107-116.
[3] Aniel, F.I., Cherubini, K., Yurgel, L.S., et al. (2011) The role of epigenetic transcription repression and DNA methyltransferases in cancer. Cancer, 117, 677-687.
[4] Hibi, K., Sakata, M., Yokomizo, K., et al. (2010) Methylation of the MGMT gene is frequently detected in advanced gastric car-cinoma. British Journal of Cancer, 102, 704-712.
[5] Wang, L., Liu, H., Zhang, Z., et al. (2006) Association of genetic variants of 06-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic Whites. Cancer Epidemiology, Biomarkers & Prevention, 15, 2364-2369.
[6] 张晖, 梁寒, 战忠利, 等 (2007) MGMT与hMLHl在胃癌组织中的表达及其临床相关性研究. 中华肿瘤防治杂志, 8, 819-821.
[7] 蔡建春, 刘棣, 张海萍, 等 (2007) 胃癌组织中相关肿瘤抑制基因启动子区甲基化状态. 中华医学杂志, 14, 978-981.
[8] Parkinsen, J.F., Wheeler, H.R., Clarkson, A., et al. (2008) Variation of O6-methylguanine-DNA methyltransferase (MGMT) promoter rmethyla-tion in serial samples in gliobhstoma. Journal of Neuro-Oncology, 87, 71-78.
[9] Verena, V., Annie-Claire, D., Alexandre, M., et al. (2008) Infrequent promoter methylation of the MGMT gene in liver metastases from uveal mela-noma. International Journal of Cancer, 123, 1215-1218.
[10] Shi, J., Zhang, G., Yao, D., et al. (2012) Prognostic sig-nificance of aberrant gene methylation in gastric cancer. Cancer Research, 2, 116-129.
[11] Chen, H., Suzuki, M., Nakamura, Y., et al. (2006) Aberrant methylation of RASGFR2 and RASSFlA in human non-small cell lung cancer. Oncology Reports, 15, 1281-1285.
[12] Vos, M.D., Dallol, A., Eckfeld, K., et al. (2006) The RASSFIA tumor sup-pressor activates Bax via MOAP-1. The Journal of Biological Chemistry, 281, 4557-4563.
[13] Guo, W., Dong, Z., Chen, Z., et al. (2009) Aberrant CpG island hypermethylation of RASSFlA in gastric cardia adenocarcinoma. Cancer Investigation, 27, 459-465.
[14] Ye, M., Xia, B., Guo, Q., et al. (2007) Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China. BMC Cancer, 7, 120.
[15] Byun, D.S., Lee, M.G., Chae, K.S., et al. (2001) Frequent epigenetic inactivation of RASSFlA by aberrant promoter hypermethylation in hu•man gastric adenocarcinoma. Cancer Research, 61, 7034-7038.